[Gastroenteropancreatic neuroendocrine tumors : (GEP-NENs)]

Christian Sebesta1, Alexandra Feichter2, Flonza Selimi1

  • 12. Medizinische Abteilung für Hämatologie, Onkologie, Gastroenterologie, Hepatologie, Allgemeine Innere Medizin, Klinik Donaustadt, Langobardenstraße 122, 1220, Wien, Österreich.

Insights

Neuroendocrine neoplasms (NENs) are diverse cancers needing a team approach. This review covers current diagnostics and treatments, noting surgery is an option even for metastatic G1/G2 NENs.

Area of Science:

  • Oncology
  • Medical Diagnostics
  • Therapeutics

Context:

  • Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of malignancies.
  • Patient management necessitates a multidisciplinary treatment strategy.
  • Current diagnostic and therapeutic approaches require a comprehensive overview.

Purpose:

  • To provide a concise review of the current state-of-the-art in diagnostics and therapy for NENs.
  • To highlight key treatment considerations for different NEN subgroups.
  • To emphasize the potential of nuclear medicine in NEN management.

Summary:

  • NENs are highly heterogeneous malignancies requiring a multidisciplinary approach.
  • Surgery is indicated for G1/G2 NENs, even in metastatic cases.
  • Guidelines and clinical studies are essential for subgroup-specific treatment details.
  • Nuclear medicine presents promising avenues for NEN diagnostics and therapy.

Impact:

  • Informs clinicians on current NEN diagnostic and therapeutic strategies.
  • Highlights the importance of a multidisciplinary approach in NEN patient care.
  • Underscores the need for further research into nuclear medicine applications for NENs.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
242
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
132
Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.5K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
122